Stock STAGR STALLERGENES GREER
Add to a list
To use this feature you must be a member
Log inSign up

News Stallergenes Greer

Equities

STAGR

GB00BZ21RF93

Real-time Euronext Paris
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Stallergenes Greer +0.14% +29.68%
2023 Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes CI
2023 Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes
CI
Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch
CI
Stallergenes Greer Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Stallergenes Greer Strengthens Precision Medicine Approach in Allergen Immunotherapy with Imperial College London Research Collaboration
CI
Stallergenes Greer and Aptar Pharma Announce Partnership to Develop Novel Connected Device for Allergen Immunotherapy Treatment Delivery
CI
Stallergenes Greer and Alyatec Announce Research Collaboration to Advance Precision Medicine in Allergen Immunotherapy
CI
Stallergenes Greer Ltd Announces Alustal®, Subcutaneous Allergen Immunotherapy Treatment Now Available
CI
Stallergenes Greer and Anergis Report Successful Preclinical Study Results with COP-Virosomes as Second-Generation Allergen Immunotherapy
CI
Stallergenes Greer Announces Submission of A Marketing Authorization Application for STAGR320
CI
Stallergenes Greer plc(ENXTPA:STAGR) dropped from CAC All-Tradable Index
CI
Stallergenes Greer plc(ENXTPA:STAGR) dropped from CAC Small Index
CI
Stallergenes Greer plc(ENXTPA:STAGR) dropped from CAC Small Index
CI
Ares Life Sciences I SARL completed the acquisition of remaining 16.13% stake in Stallergenes Greer plc from a group of shareholders.
CI
Stallergenes Greer plc Reports Unaudited Revenue Results for the First Quarter of 2019; Confirms Earnings Guidance for the Full Year 2019
CI
Transcript : Stallergenes Greer plc, 2018 Earnings Call, Mar 21, 2019
French healthcare group Stallergenes to be bought out by Bertarelli vehicle
RE
Stallergenes Greer Reports Consolidated Earnings Results for the Year Ended December 31, 2018; Provides Earnings Guidance for the Full Year 2019
CI
Ares Life Sciences I SARL reached an agreement to acquire remaining 16.13% stake in Stallergenes Greer plc from a group of shareholders for approximately €120 million.
CI
Stallergenes Greer plc Announces Unaudited Sales Results for the Full Year Ended December 31, 2018
CI
Stallergenes Greer Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. STAGR Stock
  4. News Stallergenes Greer